BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3015550)

  • 1. A reduced pancreatic protein secretion in response to cholecystokinin (CCK) in the obese Zucker rat correlates with a reduced receptor capacity for CCK.
    Praissman M; Izzo RS
    Endocrinology; 1986 Aug; 119(2):546-53. PubMed ID: 3015550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased pancreatic CCK receptor binding and CCK-stimulated amylase release in Zucker obese rats.
    McLaughlin CL; Peikin SR; Baile CA
    Physiol Behav; 1984 Jun; 32(6):961-5. PubMed ID: 6208569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas.
    Bell RH; Kuhlmann ET; Jensen RT; Longnecker DS
    Cancer Res; 1992 Jun; 52(12):3295-9. PubMed ID: 1596887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of sulfhydryl-modifying reagents on cholecystokinin-receptor interactions in guinea pig gastric glands.
    Ramani N; Praissman M
    Endocrinology; 1989 Jun; 124(6):2821-9. PubMed ID: 2721447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
    Knapp RJ; Vaughn LK; Fang SN; Bogert CL; Yamamura MS; Hruby VJ; Yamamura HI
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1278-86. PubMed ID: 2262906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
    Zhou W; Povoski SP; Longnecker DS; Bell RH
    Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The somatostatin receptor on isolated pancreatic acinar cell plasma membranes. Identification of subunit structure and direct regulation by cholecystokinin.
    Sakamoto C; Goldfine ID; Williams JA
    J Biol Chem; 1984 Aug; 259(15):9623-7. PubMed ID: 6146617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W; Povoski SP; Bell RH
    J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cholecystokinin activity by albumin.
    Huang SC; Talkad VD; Fortune KP; Jonnalagadda S; Severi C; Delle Fave G; Gardner JD
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10312-6. PubMed ID: 7479774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin-A specific antagonism of KSG-504 to cholecystokinin receptor binding and pancreatic secretion in mammals.
    Yamazaki Y; Shinagawa K; Takeda H; Kobayashi M; Akahane M; Ajisawa Y
    Jpn J Pharmacol; 1995 Dec; 69(4):367-73. PubMed ID: 8786640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internalization and cellular processing of cholecystokinin in rat pancreatic acinar cells.
    Izzo RS; Pellecchia C; Praissman M
    Am J Physiol; 1988 Dec; 255(6 Pt 1):G738-44. PubMed ID: 3202169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptors on rat pancreatic acinar cells. Pharmacological and structural characterization and demonstration of down-regulation in streptozotocin diabetes.
    Srikant CB; Patel YC
    J Biol Chem; 1986 Jun; 261(17):7690-6. PubMed ID: 2872218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCKA receptor activation stimulates p130(Cas) tyrosine phosphorylation, translocation, and association with Crk in rat pancreatic acinar cells.
    Ferris HA; Tapia JA; GarcĂ­a LJ; Jensen RT
    Biochemistry; 1999 Feb; 38(5):1497-508. PubMed ID: 9931015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin receptor binding levels in the genetically obese rat brain.
    Finkelstein JA; Steggles AW; Martinez PA; Praissman M
    Peptides; 1984; 5(1):11-4. PubMed ID: 6324145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulus-secretion coupling in the developing exocrine pancreas: secretory responsiveness to cholecystokinin.
    Chang A; Jamieson JD
    J Cell Biol; 1986 Dec; 103(6 Pt 1):2353-65. PubMed ID: 3023399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of A- and B-subtypes of cholecystokinin/gastrin receptors in the developing calf pancreas.
    Le Meuth V; Philouze-Rome V; Le Huerou-Luron I; Formal M; Vaysse N; Gespach C; Guilloteau P; Fourmy D
    Endocrinology; 1993 Sep; 133(3):1182-91. PubMed ID: 8365360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors.
    Chang RS; Lotti VJ; Chen TB; Kunkel KA
    Mol Pharmacol; 1986 Sep; 30(3):212-7. PubMed ID: 3018478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cholecystokinin binding sites in rat cerebral cortex using a 125I-CCK-8 probe resistant to degradation.
    Praissman M; Martinez PA; Saladino CF; Berkowitz JM; Steggles AW; Finkelstein JA
    J Neurochem; 1983 May; 40(5):1406-13. PubMed ID: 6300335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.